Healthcare companies by risk reading
Healthcare companies by risk reading: 1,214 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 1 September 2026.
Composite readings for 8,308 companies, recomputed 1 September 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Enanta Pharmaceuticals Inc ENTA | 62 | Stretched | Healthcare | United States | 5 / 6 | $388M |
| Alpha Teknova Inc TKNO | 68 | Stretched | Healthcare | United States | 5 / 6 | $385M |
| Auna S.A. - Cls A AUNA | 28 | Normal | Healthcare | Luxembourg | 5 / 6 | $383M |
| Orthofix Medical Inc OFIX | 57 | Elevated | Healthcare | United States | 5 / 6 | $382M |
| EyePoint Pharmaceuticals Inc EYPT | 74 | Stretched | Healthcare | United States | 5 / 6 | $382M |
| Egetis Therapeutics AB (publ) EGTX | 65 | Stretched | Healthcare | Sweden | 4 / 6 | $379M |
| Formycon AG FYB | 76 | Stretched | Healthcare | Germany | 5 / 6 | $378M |
| Simulations Plus Inc SLP | 55 | Elevated | Healthcare | United States | 4 / 6 | $372M |
| Century Therapeutics Inc IPSC | 30 | Normal | Healthcare | United States | 4 / 6 | $370M |
| Mobia Medical, Inc. MOBI | 68 | Stretched | Healthcare | United States | 5 / 6 | $369M |
| Zhejiang Taimei Medical Technology Co., Ltd. A2V | 53 | Elevated | Healthcare | China | 5 / 6 | $366M |
| Shin Nippon Biomedical Laboratories Ltd YB3 | 42 | Elevated | Healthcare | Japan | 5 / 6 | $364M |
| Jiangsu Recbio Technology Co., Ltd. G93 | 79 | Stretched | Healthcare | China | 4 / 6 | $363M |
| Upstream Bio Inc UPB | 56 | Elevated | Healthcare | United States | 5 / 6 | $363M |
| Viva Biotech Holdings VB0 | 47 | Elevated | Healthcare | China | 5 / 6 | $359M |
| OrbusNeich Medical Group Holdings Limited Q8T | 35 | Normal | Healthcare | Hong Kong | 5 / 6 | $357M |
| Q32 Bio Inc QTTB | 22 | Normal | Healthcare | United States | 4 / 6 | $353M |
| Coltene Holding AG CLTN | 38 | Normal | Healthcare | Switzerland | 5 / 6 | $352M |
| Optima Health plc J3N | 15 | Contained | Healthcare | United Kingdom | 5 / 6 | $345M |
| Oceania Healthcare Ltd OCA | 48 | Elevated | Healthcare | New Zealand | 4 / 6 | $341M |
| Cellectis CLLS | 47 | Elevated | Healthcare | France | 5 / 6 | $337M |
| Foghorn Therapeutics Inc FHTX | 39 | Normal | Healthcare | United States | 5 / 6 | $337M |
| Viemed Healthcare Inc VMD | 26 | Normal | Healthcare | United States | 5 / 6 | $337M |
| Sutro Biopharma Inc STRO | 61 | Stretched | Healthcare | United States | 4 / 6 | $335M |
| Lyell Immunopharma Inc LYEL | 68 | Stretched | Healthcare | United States | 4 / 6 | $335M |
| Abeona Therapeutics Inc ABEO | 52 | Elevated | Healthcare | United States | 4 / 6 | $333M |
| ANTENGENE CORP. DL-0001 722 | 58 | Elevated | Healthcare | China | 5 / 6 | $331M |
| Vanda Pharmaceuticals Inc VNDA | 70 | Stretched | Healthcare | United States | 5 / 6 | $326M |
| Lavipharm S.A LAVI | 31 | Normal | Healthcare | Greece | 5 / 6 | $326M |
| CLINUVEL PHARMAC.ADRS1 UR9A | 30 | Normal | Healthcare | Australia | 4 / 6 | $321M |
| Sanara MedTech Inc SMTI | 29 | Normal | Healthcare | United States | 5 / 6 | $321M |
| Anbio Biotechnology - Class A NNNN | 49 | Elevated | Healthcare | Germany | 4 / 6 | $320M |
| Adicon Holdings Limited K0U | 57 | Elevated | Healthcare | China | 5 / 6 | $319M |
| NEWRON PHARMACEUT. EO-20 NP5 | 42 | Elevated | Healthcare | Italy | 5 / 6 | $318M |
| Agenus Inc AGEN | 44 | Elevated | Healthcare | United States | 5 / 6 | $317M |
| INC Research Holdings Inc INCR | 51 | Elevated | Healthcare | Israel | 5 / 6 | $315M |
| InflaRx N.V. IFRX | 67 | Stretched | Healthcare | Germany | 5 / 6 | $314M |
| Emergent Biosolutions Inc EBS | 46 | Elevated | Healthcare | United States | 4 / 6 | $313M |
| AVITA Medical Inc RCEL | 55 | Elevated | Healthcare | United States | 5 / 6 | $312M |
| INTERGRATED DIA.H DL 025 8I8 | 16 | Contained | Healthcare | Jersey | 5 / 6 | $311M |
| Clinuvel Pharmaceuticals Limited UR9 | 30 | Normal | Healthcare | Australia | 4 / 6 | $310M |
| Semler Scientific Inc SMLR | 43 | Elevated | Healthcare | United States | 5 / 6 | $308M |
| Myriad Genetics Inc MYGN | 70 | Stretched | Healthcare | United States | 4 / 6 | $308M |
| Treace Medical Concepts Inc TMCI | 60 | Stretched | Healthcare | United States | 5 / 6 | $307M |
| LAVIPHARM S.A. NA EO 1 BXA0 | 31 | Normal | Healthcare | Greece | 5 / 6 | $306M |
| RxSight Inc RXST | 52 | Elevated | Healthcare | United States | 5 / 6 | $305M |
| TriSalus Life Sciences Inc TLSI | 53 | Elevated | Healthcare | United States | 5 / 6 | $304M |
| Orchestra BioMed Holdings Inc OBIO | 40 | Elevated | Healthcare | United States | 5 / 6 | $303M |
| CYBERDYNE Inc 8C4 | 38 | Normal | Healthcare | Japan | 5 / 6 | $301M |
| ProQR Therapeutics N.V PRQR | 52 | Elevated | Healthcare | Netherlands | 5 / 6 | $301M |
| Ocuphire Pharma Inc IRD | 69 | Stretched | Healthcare | United States | 3 / 6 | $299M |
| CapsoVision Inc CV | 62 | Stretched | Healthcare | United States | 5 / 6 | $292M |
| Fuji Pharma Co. Ltd FUP | 35 | Normal | Healthcare | Japan | 5 / 6 | $292M |
| Amarin Corp AMRN | 65 | Stretched | Healthcare | Ireland | 3 / 6 | $292M |
| Embecta Corp EMBC | 42 | Elevated | Healthcare | United States | 4 / 6 | $291M |
| Santhera Pharmaceuticals Holding AG SANN | 53 | Elevated | Healthcare | Switzerland | 5 / 6 | $290M |
| YSB Inc. B1S | 34 | Normal | Healthcare | China | 5 / 6 | $285M |
| Invivyd Inc IVVD | 48 | Elevated | Healthcare | United States | 5 / 6 | $281M |
| Tristel TSTL | 13 | Contained | Healthcare | United Kingdom | 5 / 6 | $280M |
| Anika Therapeutics Inc ANIK | 45 | Elevated | Healthcare | United States | 5 / 6 | $279M |
| Fate Therapeutics Inc FATE | 77 | Stretched | Healthcare | United States | 5 / 6 | $279M |
| Cartesian Therapeutics Inc RNAC | 65 | Stretched | Healthcare | United States | 4 / 6 | $279M |
| Lineage Cell Therapeutics Inc LCTX | 56 | Elevated | Healthcare | United States | 4 / 6 | $278M |
| Biodesix Inc BDSX | 50 | Elevated | Healthcare | United States | 5 / 6 | $278M |
| Entrada Therapeutics Inc TRDA | 63 | Stretched | Healthcare | United States | 5 / 6 | $275M |
| ELAN CORP. 25E | 22 | Normal | Healthcare | Japan | 5 / 6 | $269M |
| Thor Medical ASA TRMED | 63 | Stretched | Healthcare | Norway | 3 / 6 | $267M |
| YD Bio Ltd YDES | 64 | Stretched | Healthcare | Taiwan | 5 / 6 | $263M |
| ACOTEC SCIEN.H. DL-00001 7W3 | 18 | Contained | Healthcare | China | 5 / 6 | $261M |
| Surrozen Inc SRZN | 69 | Stretched | Healthcare | United States | 5 / 6 | $259M |
| Whitehawk Therapeutics Inc WHWK | 69 | Stretched | Healthcare | United States | 5 / 6 | $259M |
| Standard BioTools Inc LAB | 79 | Stretched | Healthcare | United States | 4 / 6 | $259M |
| Aurora Cannabis Inc ACB | 60 | Stretched | Healthcare | Canada | 5 / 6 | $256M |
| Mediantechn ALMDT | 69 | Stretched | Healthcare | France | 5 / 6 | $256M |
| Tetratherix Ltd TTX | 67 | Stretched | Healthcare | Australia | 4 / 6 | $255M |
| Prim S.A 5P1 | 21 | Normal | Healthcare | Spain | 4 / 6 | $255M |
| Macrogenics Inc MGNX | 64 | Stretched | Healthcare | United States | 4 / 6 | $254M |
| Alector Inc ALEC | 70 | Stretched | Healthcare | United States | 5 / 6 | $252M |
| Akebia Therapeutics Inc AKBA | 34 | Normal | Healthcare | United States | 5 / 6 | $250M |
| Profound Medical Corp PROF | 36 | Normal | Healthcare | Canada | 5 / 6 | $248M |
| Orasure Technologies Inc OSUR | 72 | Stretched | Healthcare | United States | 5 / 6 | $248M |
| Starpharma Holdings Ltd SPL | 50 | Elevated | Healthcare | Australia | 4 / 6 | $247M |
| Niagen Bioscience Inc NAGE | 23 | Normal | Healthcare | United States | 5 / 6 | $247M |
| So-Young International Inc SY | 72 | Stretched | Healthcare | China | 4 / 6 | $247M |
| Compugen Ltd CGEN | 13 | Contained | Healthcare | Israel | 5 / 6 | $242M |
| InfuSystem Holdings Inc INFU | 20 | Normal | Healthcare | United States | 5 / 6 | $242M |
| AC Immune SA ACIU | 74 | Stretched | Healthcare | Switzerland | 5 / 6 | $241M |
| Tonix Pharmaceuticals Holding Corp TNXP | 69 | Stretched | Healthcare | United States | 4 / 6 | $237M |
| Eurobio Scientific SA ALERS | 40 | Elevated | Healthcare | France | 5 / 6 | $233M |
| Electromed Inc ELMD | 30 | Normal | Healthcare | United States | 4 / 6 | $232M |
| Avidity Biosciences Inc RNA | 48 | Elevated | Healthcare | United States | 5 / 6 | $228M |
| Innate Pharma S.A IDD | 74 | Stretched | Healthcare | France | 5 / 6 | $227M |
| Utah Medical Products Inc UTMD | 40 | Elevated | Healthcare | United States | 5 / 6 | $226M |
| Sol-Gel Technologies Ltd SLGL | 26 | Normal | Healthcare | Israel | 5 / 6 | $226M |
| SIGA Technologies Inc SIGA | 46 | Elevated | Healthcare | United States | 5 / 6 | $226M |
| Atrys Health SL ATRY | 61 | Stretched | Healthcare | Spain | 5 / 6 | $223M |
| Organogenesis Holdings Inc - Class A ORGO | 39 | Normal | Healthcare | United States | 5 / 6 | $221M |
| High Tide Inc HITI | 35 | Normal | Healthcare | Canada | 5 / 6 | $221M |
| Spok Holdings Inc SPOK | 40 | Elevated | Healthcare | United States | 4 / 6 | $220M |
| Keros Therapeutics Inc KROS | 10 | Contained | Healthcare | United States | 5 / 6 | $220M |
By sector
Industrials 1,536Technology 1,292Healthcare 1,214Consumer Cyclical 1,116Basic Materials 577Communication Services 565Real Estate 552Consumer Defensive 536Energy 356Utilities 232
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.